HCM
HUTCHMED (China) Limited
There isn't enough reported data to score HCM yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
HCM Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Strong |
HCM's profitability and balance sheet are currently strong. There isn't enough data to rate its revenue and cash flow.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
HCM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.1x | $2.63 | -82% |
| Current | 5.7x | $14.85 | — |
| Fair | 5.8x | $3.00 | -80% |
| Expensive | 67x | $34.83 | +135% |
Historical ranges are pointers, not guarantees.
HCM's PE is 5.7x, but its earnings don't support one, so it isn't a reliable read right now.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
HCM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
HCM has the edge over HIMS on the outlook, with more favorable profitability expectations.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
HCM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.52 | +1200% |
| Q2 2025 | $0.53 | +$0.57 |
| Q4 2024 | $0.04 | -67% |
| Q2 2024 | -$0.04 | +$0.01 |
| Q4 2023 | $0.12 | +$0.55 |
| Q2 2023 | -$0.05 | +$0.25 |
| Q4 2022 | -$0.43 | -$0.18 |
| Q2 2022 | -$0.30 | -$0.05 |
HCM has the edge over HIMS in the latest year-over-year earnings comparison.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
HCM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $270.8M | -17% |
| Q2 2025 | $277.7M | -9.2% |
| Q4 2024 | $324.5M | +6.4% |
| Q2 2024 | $305.7M | -43% |
| Q4 2023 | $305.1M | +36% |
| Q2 2023 | $532.9M | +164% |
| Q4 2022 | $224.4M | +13% |
| Q2 2022 | $202M | +28% |
HCM's revenue has slid since its 2023 peak: $271M last quarter, down 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -13% | +17 points |
| Q2 2025 | -1.3% | -22 points |
| Q4 2024 | -5% | +89 points |
| Q2 2024 | -9% | +88 points |
| Q4 2023 | -31% | +62 points |
| Q2 2023 | 21% | +112 points |
| Q4 2022 | -94% | +3.8 points |
| Q2 2022 | -97% | -24 points |
HCM's operating margin was −13% last quarter, up 17 points from the same quarter a year ago.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over HCM in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
HCM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $3.4M | -90% |
| Q2 2025 | -$82.2M | -$32.2M |
| Q4 2024 | $32.5M | +$47.9M |
| Q2 2024 | -$49.9M | -125% |
| Q4 2023 | -$15.4M | +$184.3M |
| Q2 2023 | $202M | +$307.7M |
| Q4 2022 | -$199.7M | -$59.3M |
| Q2 2022 | -$105.6M | -$25.4M |
HCM has burned cash in most quarters: −$96M over the past year, against −$119M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS still generates free cash flow, though less than at its 2024 peak: $8M over the past year.
HCM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +327K shares |
| 1 year | +0.4% | +3.7M shares |
| 3 years | +31% | +207M shares |
| 5 years | +46% | +273M shares |
HCM has 873M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q2 2024 | $36.1M |
| Q4 2023 | — |
| Q2 2023 | $9.1M |
| Q4 2022 | — |
| Q2 2022 | $48.1M |
| Q4 2021 | $551,000 |
| Q2 2021 | $26.8M |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over HCM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
HCM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -6.5x | Net Cash |
HCM has more cash than debt.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
HCM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 79.2 | Neutral |
HCM's weekly RSI is 59 (neutral) and its Stochastic is 79 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
HCM PE vs Healthcare Sector
| Metric | HCM | Sector median | Relative |
|---|---|---|---|
| PE | 5.7x | 26x | 78% below |
| PE % | 46 | 29 | 17 pts above |
HCM is trading at 5.7x earnings, a 78% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
HCM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.2 | 4.4% above |
| 20 week MA | $13.0 | 14% above |
| 50 week MA | $13.4 | 11% above |
| 100 week MA | $14.3 | 4% above |
| 200 week MA | $15.4 | 3.8% below |
HCM has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
HCM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.5 | $29.5 | +16% |
| 2021 | $29.5 | $35.3 | +20% |
| 2022 | $35.3 | $14.0 | -60% |
| 2023 | $14.0 | $18.1 | +29% |
| 2024 | $18.1 | $14.3 | -21% |
| 2025 | $14.3 | $13.8 | -3.5% |
| 2026 YTD | $13.8 | $14.9 | +7.8% |
HCM has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.